MicroRNA-9 inhibits vasculogenic mimicry of glioma cell lines by suppressing Stathmin expression
Authors:
- 17 September 2013
- journal article
- laboratory investigation
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 115 (3) , 381-390
Abstract
The purpose of this study was to investigate the functions of microRNA-9, which is a tissue-specific microRNA in central nervous system, in the vasculogenic mimicry (VM) of glioma cell lines in vitro and in vivo.Glioma cell lines U87MG, U251 and SHG44 were transfected with microRNA-9 mimic, microRNA-9 inhibitor or scramble sequences. The amount of microRNA-9 and Stathmin (STMN1) mRNA was determined by quantitative real-time PCR, and the protein expression of STMN1 was determined by western blot. Cell proliferation and apoptosis were assessed. The interactions between the 3′UTR of STMN1 and miR-9 was determined by luciferase reporter assay. The VM capacity in vitro was evaluated using VM formation assay, and the rescue experiment of STMN1 was carried out in U251 cells. The in vivo experiment was applied with animal models implanted with U87MG cells.MicroRNA-9 mimic transfection reduced proliferation and increased apoptosis in glioma cell lines (p < 0.05). MicroRNA-9 mimic up-regulated STMN1 mRNA levels but reduced its protein levels (p < 0.05), and luciferase activity of STMN1 was suppressed by microRNA-9 mimic transfection (p < 0.05). Furthermore, microRNA-9 mimic transfection suppressed tumor volume growth, as well as VM both in vitro and in vivo. The cell viability and microtube density were upregulated in U251 cells after STMN1 up-regulation (p < 0.05). STMN1 is a target of microRNA-9, and microRNA-9 could modulate cell proliferation, VM and tumor volume growth through controlling STMN1 expression. MicroRNA-9 and its targets may represent a novel panel of molecules for the development of glioma treatment.Keywords
This publication has 46 references indexed in Scilit:
- Stathmin expression in glioma-derived microvascular endothelial cells: A novel therapeutic targetOncology Reports, 2011
- NF-kappaB P50/P65 hetero-dimer mediates differential regulation of CD166/ALCAM expression via interaction with micoRNA-9 after serum deprivation, providing evidence for a novel negative auto-regulatory loopNucleic Acids Research, 2011
- MicroRNA-9 Reveals Regional Diversity of Neural Progenitors along the Anterior-Posterior AxisDevelopmental Cell, 2011
- Stathmin 1: a novel therapeutic target for anticancer activityExpert Review of Anticancer Therapy, 2008
- Nitrosoureas Inhibit the Stathmin-Mediated Migration and Invasion of Malignant Glioma CellsCancer Research, 2008
- [MiR-9 regulates the expression of CBX7 in human glioma].2008
- EGFR expression in urothelial carcinoma of the upper urinary tract is associated with disease progression and metaplastic morphologyAPMIS, 2008
- Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinomaThe Journal of Pathology, 2006
- A microRNA array reveals extensive regulation of microRNAs during brain developmentRNA, 2003
- Cell shape, cytoskeletal mechanics, and cell cycle control in angiogenesisJournal of Biomechanics, 1995